Published in Nat Med on July 01, 1995
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol (2001) 4.02
Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J Clin Microbiol (1996) 2.95
Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol (1997) 2.72
The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol (2008) 2.71
Infection control in cystic fibrosis. Clin Microbiol Rev (2004) 2.45
Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis (1998) 2.43
Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. J Clin Microbiol (1999) 2.36
Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis (2002) 2.26
Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23
Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ (1998) 2.22
Invasion and intracellular survival of Burkholderia cepacia. Infect Immun (2000) 1.74
Airway mucus: From production to secretion. Am J Respir Cell Mol Biol (2006) 1.73
The Burkholderia cepacia epidemic strain marker is part of a novel genomic island encoding both virulence and metabolism-associated genes in Burkholderia cenocepacia. Infect Immun (2004) 1.60
An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis (1999) 1.59
Infectious diseases: an ecological perspective. BMJ (1996) 1.53
Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J Clin Microbiol (2001) 1.50
Regulation of ornibactin biosynthesis and N-acyl-L-homoserine lactone production by CepR in Burkholderia cepacia. J Bacteriol (2001) 1.49
Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect Immun (1998) 1.47
Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products. Infect Immun (1997) 1.44
Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR. J Clin Microbiol (1999) 1.43
Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. J Clin Microbiol (2001) 1.43
Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study. J Clin Microbiol (2003) 1.37
A melanin pigment purified from an epidemic strain of Burkholderia cepacia attenuates monocyte respiratory burst activity by scavenging superoxide anion. Infect Immun (1999) 1.34
Identification of a novel virulence factor in Burkholderia cenocepacia H111 required for efficient slow killing of Caenorhabditis elegans. Infect Immun (2004) 1.30
Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers. J Clin Microbiol (1997) 1.29
Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. J Clin Microbiol (2000) 1.24
Distribution of quorum-sensing genes in the Burkholderia cepacia complex. Infect Immun (2001) 1.23
Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis. J Clin Microbiol (2003) 1.23
Burkholderia cenocepacia ZmpB is a broad-specificity zinc metalloprotease involved in virulence. Infect Immun (2006) 1.22
Patterns of epithelial cell invasion by different species of the Burkholderia cepacia complex in well-differentiated human airway epithelia. Infect Immun (2002) 1.21
Cable-piliated Burkholderia cepacia binds to cytokeratin 13 of epithelial cells. Infect Immun (2000) 1.20
Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice. Infect Immun (2001) 1.19
Identification of IS1356, a new insertion sequence, and its association with IS402 in epidemic strains of Burkholderia cepacia infecting cystic fibrosis patients. J Clin Microbiol (1996) 1.16
Quorum-sensing mutations affect attachment and stability of Burkholderia cenocepacia biofilms. Appl Environ Microbiol (2005) 1.13
Variation in flagellin genes and proteins of Burkholderia cepacia. J Bacteriol (1998) 1.13
Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Infect Immun (1997) 1.11
PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients. J Clin Microbiol (2001) 1.10
Capillary electrophoresis-single-strand conformation polymorphism analysis for rapid identification of Pseudomonas aeruginosa and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1999) 1.08
Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients. Eur J Clin Microbiol Infect Dis (2008) 1.07
Six-year molecular analysis of Burkholderia cepacia complex isolates among cystic fibrosis patients at a referral center for lung transplantation. J Clin Microbiol (2002) 1.06
Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy. J Clin Microbiol (2005) 1.02
Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection. J Clin Microbiol (2001) 1.01
Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus. Infect Immun (2014) 1.00
A murine model for infection with Burkholderia cepacia with sustained persistence in the spleen. Infect Immun (1999) 1.00
Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia. Eur J Pediatr (1998) 0.99
Cable pili and the 22-kilodalton adhesin are required for Burkholderia cenocepacia binding to and transmigration across the squamous epithelium. Infect Immun (2005) 0.98
Burkholderia (basonym Pseudomonas) cepacia binding to lipid receptors. Infect Immun (1996) 0.97
Use of suppression-subtractive hybridization to identify genes in the Burkholderia cepacia complex that are unique to Burkholderia cenocepacia. J Bacteriol (2005) 0.96
Genetic characterization of a multicomponent signal transduction system controlling the expression of cable pili in Burkholderia cenocepacia. J Bacteriol (2004) 0.89
Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex. J R Soc Med (2000) 0.88
Oxidative stress of Burkholderia cenocepacia induces insertion sequence-mediated genomic rearrangements that interfere with macrorestriction-based genotyping. J Clin Microbiol (2009) 0.87
Transcriptional and posttranscriptional control of cable pilus gene expression in Burkholderia cenocepacia. J Bacteriol (2004) 0.86
Lung transplantation: infection, inflammation, and the microbiome. Semin Immunopathol (2011) 0.86
Clinical and environmental Burkholderia strains: biofilm production and intracellular survival. Curr Microbiol (2007) 0.86
Revised approach for identification of isolates within the Burkholderia cepacia complex and description of clinical isolates not assigned to any of the known genomovars. J Clin Microbiol (2007) 0.85
Molecular comparison of isolates of Burkholderia multivorans from patients with cystic fibrosis in the United Kingdom. J Clin Microbiol (2003) 0.85
Development and application of the active surveillance of pathogens microarray to monitor bacterial gene flux. BMC Microbiol (2008) 0.85
Identifying the killer in cystic fibrosis. Nat Med (1995) 0.83
IFN-γ stimulates autophagy-mediated clearance of Burkholderia cenocepacia in human cystic fibrosis macrophages. PLoS One (2014) 0.83
Transmissibility and infection control implications of Burkholderia cepacia in cystic fibrosis. Can J Infect Dis (1998) 0.83
Molecular genetic basis of ribotyping. Clin Microbiol Rev (2008) 0.82
Host evasion by Burkholderia cenocepacia. Front Cell Infect Microbiol (2012) 0.82
Cystic fibrosis. Thorax (2001) 0.80
Identification of potential diagnostic markers among Burkholderia cenocepacia and B. multivorans supernatants. J Clin Microbiol (2010) 0.80
Genetic diversity and multihost pathogenicity of clinical and environmental strains of Burkholderia cenocepacia. Appl Environ Microbiol (2009) 0.79
The Evolution of Cystic Fibrosis Care. Chest (2015) 0.78
Correlation of wbiI genotype, serotype, and isolate source within species of the Burkholderia cepacia complex. J Clin Microbiol (2004) 0.77
Human Cystic Fibrosis Macrophages Have Defective Calcium-Dependent Protein Kinase C Activation of the NADPH Oxidase, an Effect Augmented by Burkholderia cenocepacia. J Immunol (2017) 0.75
Pseudomonas and all that. Arch Dis Child (1999) 0.75
Development of a multiple-locus variable-number tandem-repeat typing scheme for genetic fingerprinting of Burkholderia cenocepacia and application to nationwide epidemiological analysis. J Clin Microbiol (2014) 0.75
The complete genome sequence of Escherichia coli K-12. Science (1997) 84.27
Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature (2001) 16.89
Resolution of recent evolutionary divergence among Escherichia coli from related lineages: the application of pulsed field electrophoresis to molecular epidemiology. J Infect Dis (1990) 8.33
Saccharomyces Ku70, mre11/rad50 and RPA proteins regulate adaptation to G2/M arrest after DNA damage. Cell (1998) 8.31
Event-related fMRI: characterizing differential responses. Neuroimage (1998) 8.30
Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci U S A (2001) 7.90
The EcoCyc and MetaCyc databases. Nucleic Acids Res (2000) 6.14
Organization of the bacterial chromosome. Microbiol Rev (1990) 6.01
Genome sequence of Halobacterium species NRC-1. Proc Natl Acad Sci U S A (2000) 5.87
Physical and chemical characterization of two- and three-stranded adenine-thymine and adenine-uracil homopolymer complexes. J Mol Biol (1966) 5.83
Detecting activations in PET and fMRI: levels of inference and power. Neuroimage (1996) 4.86
Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2006) 4.80
MultiFun, a multifunctional classification scheme for Escherichia coli K-12 gene products. Microb Comp Genomics (2000) 4.60
Evolution of the bacterial genome. Annu Rev Microbiol (1978) 4.33
Randomised, controlled trial of efficacy of midwife-managed care. Lancet (1996) 4.21
Eco Cyc: encyclopedia of Escherichia coli genes and metabolism. Nucleic Acids Res (1999) 3.90
Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med (1994) 3.89
EcoCyc: Encyclopedia of Escherichia coli genes and metabolism. Nucleic Acids Res (1998) 3.80
A functional neuroanatomy of hallucinations in schizophrenia. Nature (1995) 3.78
Effectiveness of programme for reducing cardiovascular risk for men in one general practice. BMJ (1993) 3.59
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet (2001) 3.45
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet (2001) 3.23
Drinking water turbidity and gastrointestinal illness in the elderly of Philadelphia. J Epidemiol Community Health (2000) 3.15
Prevalence of hearing loss among children 6 to 19 years of age: the Third National Health and Nutrition Examination Survey. JAMA (1998) 2.98
Histological validation of myocardial microstructure obtained from diffusion tensor magnetic resonance imaging. Am J Physiol (1998) 2.97
High interlaboratory reproducibility of DNA sequence-based typing of bacteria in a multicenter study. J Clin Microbiol (2006) 2.80
Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet (1996) 2.65
A Prothrombin Conversion Accelerator in Serum. Science (1949) 2.64
EcoCyc: an encyclopedia of Escherichia coli genes and metabolism. Nucleic Acids Res (1996) 2.51
Neural correlates of levels of emotional awareness. Evidence of an interaction between emotion and attention in the anterior cingulate cortex. J Cogn Neurosci (1998) 2.49
Conservation and variation of nucleotide sequences in Escherichia coli strains isolated from nature. J Bacteriol (1980) 2.45
Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis (1998) 2.43
Gene products of Escherichia coli: sequence comparisons and common ancestries. Mol Biol Evol (1995) 2.43
Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci (2007) 2.33
Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev (2005) 2.25
Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol (1995) 2.16
The evolution and structural anatomy of the small molecule metabolic pathways in Escherichia coli. J Mol Biol (2001) 2.15
PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J Clin Invest (1999) 2.14
A functional update of the Escherichia coli K-12 genome. Genome Biol (2001) 2.12
Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun (1989) 2.12
Characterization of the first definitive hematopoietic stem cells in the AGM and liver of the mouse embryo. Immunity (1996) 2.08
Translation of the diabetes nutrition recommendations for health care institutions: technical review. J Am Diet Assoc (1997) 2.06
The biological effects of magnesium-leached chrysotile asbestos. Br J Exp Pathol (1977) 2.03
Gingival recession due to trauma caused by a lower lip stud. Br Dent J (2002) 2.02
Restriction fragment length polymorphisms among uropathogenic Escherichia coli isolates: pap-related sequences compared with rrn operons. Infect Immun (1990) 1.95
A functional neuroanatomy of tics in Tourette syndrome. Arch Gen Psychiatry (2000) 1.94
Clearance of sized glass fibres from the rat lung and their solubility in vivo. Ann Occup Hyg (1982) 1.92
The amino acid sequence of the alpha-chain of human fibrinogen. Nature (1979) 1.92
Relation between cerebral activity and force in the motor areas of the human brain. J Neurophysiol (1995) 1.91
Health-care provision for asylum seekers and refugees in the UK. Lancet (1999) 1.89
URF6, last unidentified reading frame of human mtDNA, codes for an NADH dehydrogenase subunit. Science (1986) 1.87
Conservation and variation of nucleotide sequences within related bacterial genomes: Escherichia coli strains. J Bacteriol (1980) 1.86
Representations of metabolic knowledge. Proc Int Conf Intell Syst Mol Biol (1993) 1.86
Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol (1996) 1.85
Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J (2008) 1.82
FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. Transplantation (1994) 1.80
Refugees, asylum seekers, and general practice: room for improvement? Br J Gen Pract (2000) 1.80
Stimulation of human leukocyte thromboplastic activity by endotoxin. Proc Soc Exp Biol Med (1971) 1.79
Advances in electronic surveillance for healthcare-associated infections in the 21st Century: a systematic review. J Hosp Infect (2013) 1.79
Standards for the publication of mouse mutant studies. Genes Brain Behav (2008) 1.79
The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood (2001) 1.75
Increased levels of forkhead box M1B transcription factor in transgenic mouse hepatocytes prevent age-related proliferation defects in regenerating liver. Proc Natl Acad Sci U S A (2001) 1.75
Understanding the determinants of antimicrobial prescribing within hospitals: the role of "prescribing etiquette". Clin Infect Dis (2013) 1.74
Animal models of anxiety: an ethological perspective. Braz J Med Biol Res (1997) 1.73
HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching. Transplantation (1994) 1.71
Composition and dynamics of plasma in Saturn's magnetosphere. Science (2005) 1.66
Skeletal muscle fiber quality in older men and women. Am J Physiol Cell Physiol (2000) 1.66
Human intestinal goblet cell mucin. Can J Biochem (1976) 1.65
How the brain learns to see objects and faces in an impoverished context. Nature (1997) 1.65
Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Mol Psychiatry (2012) 1.63
Reconstruction of cardiac ventricular geometry and fiber orientation using magnetic resonance imaging. Ann Biomed Eng (2000) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Conservation and variation of nucleotide sequences within related bacterial genomes: enterobacteria. J Bacteriol (1980) 1.60
An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis (1999) 1.59
Functional components of basic fibroblast growth factor signaling that inhibit lung elastin gene expression. Am J Physiol Lung Cell Mol Physiol (2001) 1.58
Proposal concerning mechanism of evolution of the genome of Escherichia coli. Proc Natl Acad Sci U S A (1975) 1.58
The social context of drinking, drug use, and unsafe sex in the Boston Young Men Study. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.58
Widespread skeletal metastatic potential of human lung cancer revealed by green fluorescent protein expression. Cancer Res (1998) 1.55
The CepIR quorum-sensing system contributes to the virulence of Burkholderia cenocepacia respiratory infections. Microbiology (2003) 1.55
Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arthritis Rheum (1996) 1.54
Racial differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum (1992) 1.53
Concentrations and dimensions of coated and uncoated asbestos fibres in the human lung. Br J Ind Med (1980) 1.53
Multidisciplinary antimicrobial management and the role of the infectious diseases pharmacist--a UK perspective. J Hosp Infect (2003) 1.53
Syndromic surveillance of surgical site infections--a case study in coronary artery bypass graft patients. J Infect (2013) 1.53
Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors. Mol Psychiatry (2007) 1.53
Childhood sexual abuse among homosexual men. Prevalence and association with unsafe sex. J Gen Intern Med (1997) 1.49
Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators. Am J Cardiol (2000) 1.47
A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire. Eur Respir J (2005) 1.46
Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication. Ann Intern Med (1998) 1.45
Identification of a region of human fibrinogen interacting with staphylococcal clumping factor. Biochemistry (1982) 1.45
Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.44